Posted on: May 9th, 2022

by Eunice Mah 1,*, Oliver Chen 2, DeAnn J. Liska 3, and Jeffrey B. Blumberg 2

  • 1. Biofortis Research, Addison, IL 60101, USA
  • 2. Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA 02111, USA
  • 3. Consultant, Ridgefield, WA 98642, USA
  • * Author to whom correspondence should be addressed.

Academic Editor: Bahram H. Arjmandi


Dietary supplements for weight management include myriad ingredients with thermogenic, lipotropic, satiety, and other metabolic effects. Recently, the safety of this product category has been questioned. In this review, we summarize the safety evidence as well as relevant clinical findings on weight management and metabolic effects of six representative dietary supplement ingredients: caffeine, green tea extract (GTE), green coffee bean extract (GCBE), choline, glucomannan, and capsaicinoids and capsinoids. Of these, caffeine, GTE (specifically epigallocatechin gallate [EGCG]), and choline have recommended intake limits, which appear not to be exceeded when used according to manufacturers’ instructions. Serious adverse events from supplements with these ingredients are rare and typically involve unusually high intakes. As with any dietary component, the potential for gastrointestinal intolerance, as well as possible interactions with concomitant medications/supplements exist, and the health status of the consumer should be considered when consuming these components. Most of the ingredients reviewed also improved markers of metabolic health, such as glucose, lipids, and blood pressure, although the data are limited for some. In summary, weight management supplements containing caffeine, GTE, GCBE, choline, glucomannan, and capsaicinoids and capsinoids are generally safe when taken as directed and demonstrate metabolic health benefits for overweight and obese people.

View Full-Text

Mah E, Chen O, Liska DJ, Blumberg JB. Dietary Supplements for Weight Management: A Narrative Review of Safety and Metabolic Health Benefits. Nutrients. 2022 14(9), 1787;

Stay on track with clinical trials you can trust.

Get in touch with us today and subscribe to our newsletter to see how we can provide the clinical trial and scientific consulting services you need.